NUDT1 and cancer: Our work was the first to show that MTH1 is required to facilitate the formation, proliferation and tumorigenic capability of RAS-transformed tumor cells [2–4], thereby establishing a critical role for the oxidation state of the nucleotide pool in determining the malignancy of RAS-driven cancer cells.